Richard Horton

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Richard Horton, FRCP FRCPCH FMedSci, is the editor-in-chief of The Lancet since 1990.[1][2]

Education[edit | edit source]

  • Qualified in physiology and medicine from the University of Birmingham.

Honorary professor and other honors[edit | edit source]

  • Honorary professor at the London School of Hygiene and Tropical Medicine, University College London, and the University of Oslo
  • Honorary doctorates in medicine from the University of Birmingham, UK, and the Universities of Umea and Gothenburg in Sweden

Other academic positions[edit | edit source]

The World Health Organization (WHO) lists the following:[3]

  • First President of the World Association of Medical Editors
  • Council member of both the UK's Academy of Medical Sciences and the University of Birmingham
  • Senior Associate of the UK health-policy think-tank, the Nuffield Trust
  • Foreign Associate of the US Institute of Medicine, elected 2011

PACE trial[edit | edit source]

The Lancet published the PACE trial results but has not released the data. A UK Tribunal has ordered the release of this data.[4]

In a radio interview, Dr. Horton called the critics “a fairly small, but highly organized, very vocal and very damaging group of individuals who have, I would say, actually hijacked this agenda and distorted the debate so that it actually harms the overwhelming majority of patients.” He didn’t address the substance of the criticisms.[5] As of September 6, 2016, 12,233 people signed the petition Misleading PACE claims should be retracted[6] and the petition, when over 11,000 signatures, was delivered to The Lancet and made the Wall Street Journal.[7]

Richard Horton has refused to engage with scientists such as Dr. David Tuller over the PACE trial and ignored requests of a response to the PACE trial scandal. Many have tried to contact him on Twitter regarding the trial but he has refused to respond and blocked them.[8].

Open letters to Richard Horton and/or The Lancet RE: PACE trial[edit | edit source]

PACE trial headings will have Open letters from:

See also[edit | edit source]

References[edit | edit source]